Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Belle

Showing results (11-20 of 227) with videos related to

Pageof 23
Sort By:
European Heart Journal|April 7, 2007
STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry)Gilles Montalescot, Jean Dallongeville, Eric Van Belle, et al.
JACC. Case Reports|June 13, 2022
Transcatheter Occlusion of Coronary-Pulmonary Fistula With a Liquid Embolic Agent After Evaluation by FFRMehdi Saighi Bouaouina, Matthieu Perier, Kamel Kechabtia, et al.
Cardiovascular Diabetology|January 31, 2003
Influence of diabetes mellitus on heart failure risk and outcomeChristophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, et al.
European Heart Journal|April 16, 2004
Impact of diabetes mellitus on long-term survival in patients with congestive heart failurePascal De Groote, Nicolas Lamblin, Frédéric Mouquet, et al.
Acta Cardiologica|July 5, 2007
Steady endothelial nitric oxide synthase expression in heart failurePierre V Ennezat, Eric Van Belle, Philippe Asseman, et al.
Lancet (London, England)|May 31, 2011
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemiaJill Belch, William R Hiatt, Iris Baumgartner, et al.
American Heart Journal|April 1, 2009
Aldosterone and long-term outcome after myocardial infarction: A substudy of the french nationwide Observatoire sur la Prise en charge hospitalière, l'Evolution à un an et les caRactéristiques de patients présentant un infArctus du myocarde avec ou sans onde Q (OPERA) studyFarzin Beygui, Gilles Montalescot, Eric Vicaut, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 16, 2019
Time Course of Reendothelialization with Polyzene-F Nanocoated Cobra PzF™ Coronary Stent on Rabbit Iliac ArteriesLuc Maillard, Delphine Corseaux, Alexandre Altié, et al.
American Heart Journal|August 9, 2005
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failureNicolas Lamblin, Sophie Susen, Joël Dagorn, et al.
BMC Cardiovascular Disorders|September 17, 2005
A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusionsNicolas Lamblin, François J Cuilleret, Nicole Helbecque, et al.
Pageof 23

Showing results (11-20 of 227) with videos related to

Sort By:
Pageof 23
European Heart Journal|April 7, 2007
STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry)Gilles Montalescot, Jean Dallongeville, Eric Van Belle, et al.
JACC. Case Reports|June 13, 2022
Transcatheter Occlusion of Coronary-Pulmonary Fistula With a Liquid Embolic Agent After Evaluation by FFRMehdi Saighi Bouaouina, Matthieu Perier, Kamel Kechabtia, et al.
Cardiovascular Diabetology|January 31, 2003
Influence of diabetes mellitus on heart failure risk and outcomeChristophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, et al.
European Heart Journal|April 16, 2004
Impact of diabetes mellitus on long-term survival in patients with congestive heart failurePascal De Groote, Nicolas Lamblin, Frédéric Mouquet, et al.
Acta Cardiologica|July 5, 2007
Steady endothelial nitric oxide synthase expression in heart failurePierre V Ennezat, Eric Van Belle, Philippe Asseman, et al.
Lancet (London, England)|May 31, 2011
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemiaJill Belch, William R Hiatt, Iris Baumgartner, et al.
American Heart Journal|April 1, 2009
Aldosterone and long-term outcome after myocardial infarction: A substudy of the french nationwide Observatoire sur la Prise en charge hospitalière, l'Evolution à un an et les caRactéristiques de patients présentant un infArctus du myocarde avec ou sans onde Q (OPERA) studyFarzin Beygui, Gilles Montalescot, Eric Vicaut, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 16, 2019
Time Course of Reendothelialization with Polyzene-F Nanocoated Cobra PzF™ Coronary Stent on Rabbit Iliac ArteriesLuc Maillard, Delphine Corseaux, Alexandre Altié, et al.
American Heart Journal|August 9, 2005
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failureNicolas Lamblin, Sophie Susen, Joël Dagorn, et al.
BMC Cardiovascular Disorders|September 17, 2005
A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusionsNicolas Lamblin, François J Cuilleret, Nicole Helbecque, et al.
Pageof 23